PPT-Preventing and Managing C. difficile

Welcome All lines are muted so please ask your questions in chat For technical issues chat to the Technical Support Panelist Please actively participate in the poll that will pop up on the lower righthand side of your screen at the end of the presentation. Pourquoi pourrait une personne se trouver que de faire des excuses est une chose difficile?. Faites les excuses de ces personnes. (CDI). . Infections Toolkit. . Activity C: ELC Prevention Collaboratives. Last reviewed . - . 2/29/12 . --- Disclaimer: The findings and conclusions in this presentation are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.. . Infections Toolkit. . Activity C: ELC Prevention Collaboratives. Last reviewed . - . 2/29/12 . --- Disclaimer: The findings and conclusions in this presentation are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.. Kevin W. Garey, PharmD. , MS, FASHP. Professor and Chair. Department . of Pharmacy Practice and Translational Research. Update on progress of city-wide stewardship projects. Focus on a better understanding of antimicrobial resistance in the Houston area. Kevin W. Garey, PharmD. , MS, FASHP. Professor and Chair. Department . of Pharmacy Practice and Translational Research. Update on progress of city-wide stewardship projects. Focus on a better understanding of antimicrobial resistance in the Houston area. Kevin W. Garey, PharmD. , MS, FASHP. Professor and Chair. Department . of Pharmacy Practice and Translational Research. Update on progress of city-wide stewardship projects. Focus on a better understanding of antimicrobial resistance in the Houston area. OHA HEN 2.0. C. Difficile Infection (CDI). AIM. Primary Drivers. Secondary Drivers. Change Ideas. Reduce CDI by 40%. Antimicrobial Stewardship. Audit antimicrobial use prospectively and provide direct feedback to the provider. Infection. Serin. a Tart, PharmD. Antimicrobial Stewardshi. p Coordinator Clinical Pharmacist. Cape Fear Valley Health. start@capefearvalley.com. . I have no relevant financial relationships with the manufacturers of any of the products discussed in this CE activity. Clostridium difficile Infection (CDI) Guideline Update: Understanding the Data Behind the Recommendations Erik R. Dubberke, MD, MSPH Associate Professor of Medicine Washington University School of Medicine Michael Gavin MD. Division of Gastroenterology. University of New Mexico. Burden of . Clostridium difficile . Infection. in the United . States. n . engl. j med 372;9 nejm.org . february. 26, 2015. Understanding the Data Behind the Recommendations. Erik R. Dubberke, MD, MSPH. Associate Professor of Medicine. Washington University School of Medicine. Summary of Key Changes from 2010 Guidelines. Epidemiology. Prior studies show that 3 - 26% of hospitalized patients are asymptomatically colonized with C. difficile . Available assays are not able to distinguish between C. difficile infection and coloniz Owners Clostridium difficile is an important cause of disease in people and animals. These bacteria do two very important things: Some strains contain genes that allow them to produce toxins. It i Influenza, COVID, RSV, many other viruses. Masks and hand hygiene. Cleaning of surfaces with dilute bleach. Not coming to work when unwell and symptomatic. MRO = multi-resistant organisms. Same as MDR (multi-drug resistance).